sepsis
Prenosis Wins $4.8M in NIH Grants to Study Sepsis in Acute Care Settings
The firm will use two Small Business Innovation Research grants to study why patients develop sepsis and how best to treat them using its Immunix AI platform.
Prenosis Wins $749K BARDA Contract for Sepsis Prediction Software
The company will use the funding to demonstrate the clinical value of its Sepsis ImmunoScore, an AI/machine learning-based software for predicting sepsis.
VolitionRx Taking on Nucleosome-Focused Dx for Human Cancers After Canine Cancer Screening Test
Premium
The firm is working with MD Anderson Cancer Center to show that its NETosis test can predict which cancer patients are at risk for sepsis.
VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis
The study will use Volition's CE-marked Nu.Q NETs test to evaluate the role of neutrophil extracellular traps in cancer patients with sepsis.